IFPAC Scientific Board

Every year, the IFPAC Scientific Board–composed of industry, regulatory, and academic leaders—works together to create a comprehensive program that addresses important mainstay topics; they touch base on the latest trends, technologies, and applications.

CO-CHAIRS

Celeste Frankenfeld Lamm, Merck, Rahway, NJ

Celeste Frankenfeld Lamm, Ph.D., is a seasoned industry professional with 18 years of experience in the field. As the Senior Director of Global Regulatory Affairs – CMC at Merck & Co., she spearheads the company's global CMC policy efforts. In this role, Celeste engages externally with regulatory authorities, industry peers, and academia, fostering collaborations to drive innovation in manufacturing across the pharmaceutical and biotech sectors. Drawing upon her longstanding interest in advanced manufacturing, Celeste's journey began during her graduate studies, where she focused on microfluidics. Her passion for cutting-edge manufacturing and analytical techniques continued as she transitioned into her early career, leading analytical development efforts that supported the advancement of drug substance and drug product development and playing a pivotal role in successfully bringing several unique dosage forms through clinical development. In addition to her policy responsibilities, Celeste actively contributes to various industry groups. She serves on the PhRMA GQM Work Group, co-leads ISPE's Product Quality Lifecycle Implementation (PQLI) team, and sits on the planning committee for the Drug Information Association (DIA) annual conference. Furthermore, she has been a dedicated session chair at the IFPAC Conference for many years, sharing her expertise and insights. Dr. Frankenfeld Lamm holds a B.A. in Chemistry and Biology from Greenville University and earned her Ph.D. in Pharmaceutical Chemistry from the University of Kansas.

Paresma (Pinky) Patel, FDA, CDER, OPQ, Silver Spring, MD

Paresma (Pinky) Patel, Ph.D. is a Division Director in CDER’s Office of Pharmaceutical Quality, Office of Product Quality Assessment III. In this role, she leads groups responsible for the evaluation of chemistry, manufacturing, and controls (CMC) information with a focus on drug substance quality throughout clinical development to submission of marketing applications. She served as a Branch Chief, supporting the oncology and anti-viral clinical divisions, prior to transitioning to her current role. Prior to FDA, she worked as a medicinal chemist at the National Institutes of Health. Dr. Patel completed her Ph.D. in organic chemistry at The Scripps Research Institute and completed a postdoctoral fellowship at the California Institute of Technology.

Andrew Anderson, Johnson & Johnson, Beerse, Belgium

Andrew Anderson serves as the Novel and Strategic Technology Lead at Johnson & Johnson, headquartered in Beerse, Belgium. With a diverse professional background, he commenced his career in the supply chain laboratory at GSK, subsequently transitioning to Research and Development (R&D). Throughout his career, Andrew has contributed significantly to various modalities within R&D, successfully introducing cutting-edge technologies and Process Analytical Technology (PAT) solutions. Currently, he is spearheading the strategic direction for the application of analytical technology in small molecule development at Johnson & Johnson.

Colm O'Donnell, University College Dublin (UCD), Ireland

Colm O'Donnell BE PhD CEng FIAE is a Full Professor and Head of Biosystems & Food Engineering Subject at University College Dublin (UCD), Ireland. He also leads the Food Quality and Processing Pillar in UCD's Institute of Food & Health. He was awarded an EU Comett Research Fellowship in process analytical technology at the Institut National de Recherche Agronomique (INRA) in Paris and worked in the dairy processing industry prior to joining UCD. His research group works on Process Analytical Technology (Spectroscopy, Spectral Imaging, rheology) and Advanced Manufacturing research projects funded by the European Union. Irish Research Council, Science Foundation Ireland, Enterprise Ireland and industry. He is the UCD Principal Investigator in the Dairy Processing Technology Centre (www.dptc.ie) and the EU funded DiTECT project, and Co-ordinator of the EU funded FreshProof project. He was designated as a Highly Cited Researcher by Thomson Reuters based on his rankings within the top 1% highly cited researchers. He was appointed Editor of the International Journal of Food Properties and Associate Editor of Transactions of the American Society of Agricultural & Biological Engineers. He is a member of the Editorial board of Food Engineering Reviews (Springer), Foods (MDPI) and the Encyclopedia of Agricultural, Food & Biological Engineering (Taylor & Francis). He is a fellow of the Irish Academy of Engineering and member of the Food Processing Technical Committee of the American Society of Agricultural & Biological Engineers.

Members

Christian Airiau, Sanofi, Framingham, MA
Ahmad Almaya, Eli Lilly, Indianapolis, IN
Scott Armstrong, Phillips 66, Houston, TX
Bob Bear, Ametek, Pittsburgh, PA
Tara Gooen Bizjak, FDA, CDER, OC, OMQ, MGPS, Silver Spring, MD
Lucinda Buhse, FDA, CDER, OPQ, OTR, DPA, Silver Spring, MD
Brian Carlin, Consultant, Lawrenceville, NJ
Sharmista Chatterjee, FDA, CDER, OPQ, OPF, Silver Spring, MD
James Cheney, Celgene, Summit, NJ
Greg Connelly, Vertex, Boston, MA
Celia Cruz, Eli Lilly, Indianapolis, IN
Lawrence De Belder, Consultant, Beerse, Belgium
Ranjit Deshmukh
Greg Doddridge, Abbvie, North Chicago, IL
Bill Foley, Waters Corporation, Plymouth, MA
Rick Friedman, FDA, CDER, OC, OMQ, Silver Spring, MD
Neal Gallagher, Eigenvector Research, Inc., Manson, WA
Sherine George, Dow Chemical, Freeport, TX
Robert Guenard, Biogen, RTP, NC
Steve Hammond, Steve Hammond Consulting
Doug Hausner, Thermo Fisher Scientific
Walter Henslee, JPAC, McDade, TX
Ernie Hillier, EJH Consulting
David Keire, FDA, CDER, OPQ, OTR, Silver Spring, MD
Mel Koch, Consultant, Seattle, WA
Evdokia Korakianiti, EMA
Theodora Kourti, Consultant
Steve Kozlowski, FDA, CDER, OPQ, OBP, Silver Spring, MD
Gulsad Kucuk, Bristol-Myers Squibb, New Brunswick, NJ
Bogdan Kurtyka, FDA, CDER, OPQ, OPF, Silver Spring, MD
Sau (Larry) Lee, FDA,CDER,OMPT,CDER,OPQ,SS, Silver Spring, MD
Lorenz Liesum, Novartis Pharma, Basel, Switzerland
Keven Macias, Eli Lilly, Indianapolis, IN
Rapti Madurawe, FDA, CDER, OPQ, OPF, DPAI, Silver Spring, MD
Sarah Pope Miksinski, AstraZeneca, Gaithersburg, MD
Charles E. (Chuck) Miller, Aspen Technology, Lansdale, PA
Christine M. Moore, Organon, Jersey City, NJ
Moheb M. Nasr, Consultant
Thomas O’Connor, FDA, CDER, OPQ, OTR, DPQR, Silver Spring, MD
Justin Pritchard, Vertex, Boston, MA
G.K. Raju, Light Pharma, Cambridge, MA

Manoharan Ramasamy, Merck & Co., West Point, PA
Saly Romero-Torres, Biogen, RTP, NC
Sonja S. Sekulic, Pfizer, Groton, CT
Robert E. Sherman, ISA Life Fellow, Consultant, Shorewood, IL
Ryan Simpson, Eastman Chemical Company, Kingsport, TN
Rakhi Shah, FDA, CDER, OPQ, OTR, Silver Spring, MD
Geng (Michael) Tian, FDA, CDER, OPQ, OTR, Silver Spring, MD
Tim Stevens, Bristol-Myers Squibb, New Brunswick, NJ
J.D. Tate, Dow Chemical (retired), Freeport, TX
Gert Thurau, Hoffmann-LaRoche, Basel, Switzerland
Cenk Undey, Amgen, Thousand Oaks, CA
Juergen von Frese, Da-Sol, Utting am Ammersee, Germany
Tony Wang, Amgen, Houston, TX
Martin Warman, Martin Warman Consultancy, Swalecliffe, UK
Xiaoyu Zhang, Eli Lilly, Indianapolis, IN

Organization Representatives

Stephen Byrn, CPPR/PTCC/CAMP, Purdue University, West Lafayette, IN
James Drennen III and Carl Anderson, DCPT, Duquesne University, Pittsburgh, PA
Brian Marquardt, Director, CPAC, APL, Univ. of Washington, Seattle, WA
Jose Cardoso de Menezes, IST, UTL, Lisbon, Portugal
Fernando Muzzio, Rutgers University, New Brunswick, NJ
Rodolfo Romañach, Ph.D., UPR, Mayagüez, PR,
Michael J. Tarlov, NIST, Gaithersburg, MD
Seongkyu Yoon, University of Massachusetts-Lowell, Lowell, MA

IFPAC

Robert S. Zutkis, Director, IFPAC, Grayslake, IL
Julie C. Kovach, Associate Director, IFPAC, Grayslake, IL

IFPAC would like to thank each board member for their contributions to the success of the IFPAC Annual Meeting over the years!